These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32345297)

  • 21. CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICES.
    Panteli D; Kreis J; Busse R
    Int J Technol Assess Health Care; 2015 Jan; 31(5):314-23. PubMed ID: 26711222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health technology assessment (HTA) readiness in Uganda: stakeholder's perceptions on the potential application of HTA to support national universal health coverage efforts.
    Mayora C; Kazibwe J; Ssempala R; Nakimuli B; Ssennyonjo A; Ekirapa E; Byakika S; Aliti T; Musila T; Gad M; Vassall A; Ruiz F; Ssengooba F
    Int J Technol Assess Health Care; 2023 Oct; 39(1):e65. PubMed ID: 37905441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysis.
    Odeyemi IA; Nixon J
    Int J Equity Health; 2013 Jan; 12():9. PubMed ID: 23339606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme.
    Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A
    Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?
    Tanvejsilp P; Taychakhoonavudh S; Chaikledkaew U; Chaiyakunapruk N; Ngorsuraches S
    Value Health Reg Issues; 2019 May; 18():78-82. PubMed ID: 30641410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing institutionalization of health technology assessment in Kenya.
    Mbau R; Vassall A; Gilson L; Barasa E
    BMC Health Serv Res; 2023 Jun; 23(1):681. PubMed ID: 37349812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential use of routine databases in health technology assessment.
    Raftery J; Roderick P; Stevens A
    Health Technol Assess; 2005 May; 9(20):1-92, iii-iv. PubMed ID: 15899148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equitable access to health insurance for socially excluded children? The case of the National Health Insurance Scheme (NHIS) in Ghana.
    Williams GA; Parmar D; Dkhimi F; Asante F; Arhinful D; Mladovsky P
    Soc Sci Med; 2017 Aug; 186():10-19. PubMed ID: 28575734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model-based study to estimate the health and economic impact of health technology assessment in Thailand.
    Kingkaew P; Budtarad N; Khuntha S; Barlow E; Morton A; Isaranuwatchai W; Teerawattananon Y; Painter C
    Int J Technol Assess Health Care; 2022 May; 38(1):e45. PubMed ID: 35506420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of health technology assessment tools in sub-Saharan Africa: methodological issues and implications.
    Kriza C; Hanass-Hancock J; Odame EA; Deghaye N; Aman R; Wahlster P; Marin M; Gebe N; Akhwale W; Wachsmuth I; Kolominsky-Rabas PL
    Health Res Policy Syst; 2014 Dec; 12():66. PubMed ID: 25466570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach.
    Krubiner CB; Barsdorf NW; Goldstein SJ; Mosam A; Potgieter S; DiStefano MJ; Tugendhaft A; Merritt MW; Li R; Chalkidou K; Faden RR; Hofman KJ
    Int J Technol Assess Health Care; 2022 Mar; 38(1):e26. PubMed ID: 35256036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A SWOT analysis of the development of health technology assessment in Iran.
    Behzadifar M; Ghanbari MK; Azari S; Bakhtiari A; Rahimi S; Ehsanzadeh SJ; Sharafkhani N; Moridi S; Bragazzi NL
    PLoS One; 2023; 18(3):e0283663. PubMed ID: 36996128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review of the National Health Insurance Scheme in Ghana: What Are the Sustainability Threats and Prospects?
    Alhassan RK; Nketiah-Amponsah E; Arhinful DK
    PLoS One; 2016; 11(11):e0165151. PubMed ID: 27832082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region.
    Sharma M; Teerawattananon Y; Dabak SV; Isaranuwatchai W; Pearce F; Pilasant S; Sabirin J; Mayxay M; Guerrero M; Phuong NK; Sastroasmoro S; Htoo TS
    Health Res Policy Syst; 2021 Feb; 19(1):19. PubMed ID: 33573676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana.
    Gad M; Lord J; Chalkidou K; Asare B; Lutterodt MG; Ruiz F
    Value Health; 2020 Feb; 23(2):171-179. PubMed ID: 32113622
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.